ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
2
Alembic Pharmaceuticals Limited
3
Consolidated Profit & Loss account
4
Mar-18Mar-19Mar-20Mar-21
5
INCOME
6
Revenue From Operations [Gross] 3,125 3,807 4,492 5,393
7
Less: Excise/Sevice Tax/Other Levies 1 - - -
8
Revenue From Operations [Net] 3,124 3,807 4,492 5,393
9
Other Operating Revenues 6 128 114 -
10
Total Operating Revenues 3,130 3,935 4,606 5,393
11
Other Income 7 9 5 10
12
Total Revenue 3,137 3,944 4,611 5,403
13
EXPENSES
14
Cost Of Materials Consumed 726 850 979 1,185
15
Purchase Of Stock-In Trade 202 235 271 266 COGS
16
Changes In Inventories Of FG,WIP And Stock-In Trade -42 -92 -211 -194 886 993 1,039 1,257
17
Employee Benefit Expenses 623 747 906 1,051
18
Finance Costs 3 18 27 16
19
Depreciation And Amortisation Expenses 105 115 157 183
20
Other Expenses 979 1,322 1,481 1,527
21
Total Expenses 2,596 3,195 3,611 4,035
22
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 541 749 1,000 1,368
23
Exceptional Items - - - -
24
Profit/Loss Before Tax 541 749 1,000 1,368
25
Tax Expenses-Continued Operations
26
Current Tax 124 178 205 253
27
Deferred Tax -2 -17 -4 -
28
Tax For Earlier Years -1 -4 -1 -
29
Total Tax Expenses 120 157 199 253
30
Profit/Loss For The Period 421 593 801 1,115
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100